Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beximco Pharmaceuticals is a leading generic pharmaceutical manufacturer and exporter based in Bangladesh, with a growing presence in the United States through its subsidiary, Beximco USA. The company specializes in the development and manufacture of a wide range of generic medicines, including oral solids, inhalers, and sterile injectables. Beximco was the first Bangladeshi pharmaceutical company to receive US FDA approval for its manufacturing facility and has since successfully launched multiple products in the US market. Their business model focuses on providing high-quality, affordable generic versions of off-patent drugs across various therapeutic categories such as cardiovascular, respiratory, and metabolic diseases. In addition to its own product portfolio, the company provides contract manufacturing services to global pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beximco USA.